Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ONO Pharmaceutical
AddedFeb 15, 2024
UpdatedJun 28, 2026
ONO Pharmaceutical

ONO Pharmaceutical

Public

ONO Pharmaceutical: A US-based global leader in innovative pharmaceuticals and diagnostic reagents since 1717.

HQ
Cambridge, MA, US
Founded
1717
Overview
Compare
Employees

ONO Pharmaceutical is dedicated to the production, purchase, and sale of pharmaceuticals and diagnostic reagents, with a focus on prescription drugs. The company emphasizes drug discovery with high certainty and global competitiveness. Founded in 1717 in Dosho-machi, Osaka, ONO has a long history of developing innovative and breakthrough pharmaceutical products.

ONO Pharmaceutical has made significant contributions to the pharmaceutical industry, consistently delivering high-quality and effective treatments. Its commitment to innovation has positioned it as a global leader in the field, impacting healthcare outcomes worldwide.

ONO Pharmaceutical - Similar Companies

Shionogi & Co. logo

Shionogi & Co.

Novartis Pharma logo

Novartis Pharma

Fuji Pharma Co. logo

Fuji Pharma Co.

Eisai Co. logo

Eisai Co.

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

Daiichi Sankyo logo

Daiichi Sankyo

daiichisankyo.com

Astellas Pharma logo

Astellas Pharma

Nobelpharma logo

Nobelpharma

Sumitomo Pharma Co. logo

Sumitomo Pharma Co.

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Opko Health logo

Opko Health

opko.com

Eton Pharmaceuticals logo

Eton Pharmaceuticals

Oncolys BioPharma logo

Oncolys BioPharma

oncolys.com

Organon logo

Organon

organon.com

Pono Pharma logo

Pono Pharma

ONO Pharmaceutical - Quick Facts

Who are ONO Pharmaceutical's competitors?

Companies similar to ONO Pharmaceutical include Shionogi & Co., Novartis Pharma, Fuji Pharma Co. and Eisai Co..

When was ONO Pharmaceutical founded?

ONO Pharmaceutical was founded in 1717.

Where is ONO Pharmaceutical's headquarters located?

ONO Pharmaceutical's headquarters is located in Cambridge, MA, US.

How many employees does ONO Pharmaceutical have?

ONO Pharmaceutical has 3,000 employees as of Feb 4, 2024.

ONO Pharmaceutical - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Pharmaceuticals
Tags
  • Healthcare
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 11 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified